Clinical trial
Management of Superficial Thrombophlebitis
NCT00264381 · University of Oklahoma, Other · Completed
Key facts
| NCT number | NCT00264381 |
|---|---|
| Title | Management of Superficial Thrombophlebitis |
| Official title | Management of Superficial Thrombophlebitis |
| Lead sponsor | University of Oklahoma, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Superficial Thrombophlebitis, Upper Extremity Superficial Thrombophlebitis, Lower Extremity Superficial Thrombophlebitis |
| Intervention type | Drug |
| Interventions | Dalteparin sodium injection |
| Enrollment | 72 |
| Start date | Oct 1, 2002 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2011 |
| First posted | Dec 12, 2005 |
| Last update posted | Nov 18, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: